Rare Diseases Identified
Despite scientific advances, the majority of rare diseases still lack approved treatment options.
Rare Diseases
Advancing Rare Disease Therapies
Rare disease programs require a unique combination of scientific insight, regulatory understanding, and patient-centered execution. We help sponsors overcome development challenges and bring innovative therapies closer to patients who need them most.
Hero image / scientific visualization
Patient-centered rare disease research, laboratory or clinical team
Overview
Why Rare Diseases Require a Different Approach
Developing therapies for rare and ultra-rare conditions presents challenges that extend beyond traditional clinical research.
Small patient populations, limited natural history data, evolving regulatory pathways, and the need for meaningful patient engagement demand a specialized strategy at every stage of development.
Our team combines scientific expertise, operational excellence, and global rare disease experience to support successful development programs from early planning through regulatory approval.
Rare Disease Landscape
The Reality of Rare Disease Research
Diagnostic Delays
Many patients experience years of uncertainty before receiving an accurate diagnosis.
Limited Clinical Data
The scarcity of natural history information often complicates study design and endpoint selection.
Dispersed Populations
Patients may be spread across multiple countries, requiring innovative recruitment and trial strategies.
Our Development Approach
Designed Around the Unique Needs of Rare Disease Programs
Scientific, operational, regulatory, and patient-focused strategy integrated from early planning through approval.
Strategic Development Planning
Aligning scientific, clinical, regulatory, and commercial objectives from the earliest stages.
- Clinical development plans
- Target product profiles
- Regulatory roadmaps
- Risk assessment and mitigation
Natural History & Disease Understanding
Building the evidence required to understand disease progression and support development decisions.
- Natural history studies
- Patient registries
- Disease burden assessments
- Real-world evidence
Patient-Centered Trial Design
Designing studies around the realities of patients, families, and caregivers.
- Reduced patient burden
- Home-based assessments
- Flexible visit schedules
- Remote monitoring
Innovative Clinical Trial Models
Applying alternative development strategies where conventional models are not sufficient.
- Adaptive trial designs
- Single-arm studies
- Basket trials
- External control cohorts
Therapeutic Expertise
Areas of Rare Disease Experience
Genetic Disorders
Inherited and genomic conditions supported through advanced therapies and precision medicine approaches.
Neuromuscular Disorders
Progressive conditions requiring specialized functional endpoints and patient-reported outcomes.
Metabolic Disorders
Therapies for inherited metabolic diseases, enzyme deficiencies, and related conditions.
Rare Hematologic Diseases
Clinical expertise in disorders affecting blood production, function, and coagulation.
Rare Oncology
Programs targeting low-incidence cancers and molecularly defined patient populations.
Pediatric Rare Diseases
Ethical, family-centered pediatric development with age-appropriate study design.
Regulatory Expertise
Navigating Global Rare Disease Pathways
Specialized regulatory opportunities can accelerate development and improve patient access.
United States
- Orphan Drug Designation
- Fast Track Designation
- Breakthrough Therapy Designation
- Rare Pediatric Disease Programs
Europe
- Orphan Medicinal Product Designation
- PRIME Eligibility
- Pediatric Investigation Plans
- Scientific Advice Procedures
Global Markets
Strategic guidance across key international authorities to support global development and registration strategies.
Global regulatory map
Patient Recruitment & Engagement
Connecting with Rare Disease Communities
Successful recruitment begins with understanding the patient journey.
Patient journey / recruitment diagram
Awareness → Screening → Enrollment → Retention
Global Investigator Networks
Access to specialized centers with experience in rare disease diagnosis and treatment.
Advocacy Group Collaboration
Partnerships with patient organizations to improve awareness, education, and participation.
Community Engagement
Building trust through transparent communication and patient-focused study experiences.
Retention Strategies
Caregiver engagement, travel assistance, and digital support for long-term participation.
Technology & Data Solutions
Enhancing Rare Disease Research Through Innovation
Electronic Data Capture
Efficient collection, validation, and management of study data.
Real-World Evidence
Insights generated from patient registries and routine clinical practice.
Digital Biomarkers
Emerging technologies for disease monitoring and outcome measurement.
Advanced Analytics
Data science that improves decision-making throughout development.
Why Sponsors Choose Us
Specialized by Design
Specialized Rare Disease Focus
Rare diseases are not one of many therapeutic areas we support—they are at the core of our expertise.
Scientific Depth
Therapeutic and regulatory specialists dedicated to orphan and ultra-rare indications.
Operational Agility
Flexible teams and delivery models tailored to each program’s unique requirements.
Global Reach
Relationships with investigators, treatment centers, and patient communities worldwide.
Collaborative Partnership
Working as an extension of sponsor teams to achieve shared development goals.
Success Stories
Transforming Challenges into Progress
Ultra-Rare Genetic Disease Program
Protocol development, site activation, and patient recruitment for a first-in-human study.
Neuromuscular Disease Trial
Patient-centric trial solutions designed to improve enrollment and retention.
Metabolic Disease Program
Multi-country coordination across highly specialized treatment centers.
Final Call to Action
Advancing Rare Disease Innovation Together
Whether you are preparing for your first clinical study or planning a global development strategy, our rare disease experts are ready to help.